Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Gavreto. Always confirm against the full prescribing information.
100 interactions
Abacavir
The risk or severity of liver damage can be increased when Abacavir is combined with Pralsetinib.
Level 2 evidence
Abatacept
The risk or severity of liver damage can be increased when Abatacept is combined with Pralsetinib.
Level 2 evidence
Abiraterone
The risk or severity of liver damage can be increased when Abiraterone is combined with Pralsetinib.
Level 2 evidence
Abrocitinib
The serum concentration of Pralsetinib can be increased when it is combined with Abrocitinib.
Level 1 evidence
Acamprosate
The risk or severity of liver damage can be increased when Acamprosate is combined with Pralsetinib.
Level 2 evidence
Acarbose
The risk or severity of liver damage can be increased when Acarbose is combined with Pralsetinib.
Level 2 evidence
Acebutolol
The risk or severity of liver damage can be increased when Acebutolol is combined with Pralsetinib.
Level 2 evidence
Aceclofenac
The risk or severity of liver damage can be increased when Aceclofenac is combined with Pralsetinib.
Level 2 evidence
Acenocoumarol
The serum concentration of Acenocoumarol can be increased when it is combined with Pralsetinib.
Level 1 evidence
Acetaminophen
The risk or severity of liver damage can be increased when Acetaminophen is combined with Pralsetinib.
Level 2 evidence
Acetazolamide
The risk or severity of liver damage can be increased when Acetazolamide is combined with Pralsetinib.
Level 2 evidence
Acetohydroxamic acid
The risk or severity of liver damage can be increased when Acetohydroxamic acid is combined with Pralsetinib.
Level 2 evidence
Enter your NPI to unlock 7 major interactions for Gavreto
Gavreto (Pralsetinib) has 1088 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Gavreto (Pralsetinib) has 77 major, 988 moderate, and 23 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Gavreto. Always confirm against the full prescribing information.